ArticleCancer medicine2022

Lower neutrophil-to-lymphocyte ratio and positive programmed cell death ligand-1 expression are favorable prognostic markers in patients treated with pembrolizumab for urothelial carcinoma.

Yu Miyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.